Abstract
Sudden cardiac arrest (SCA) studies are often population-based, limited to sudden cardiac death, and excluding infants. To guide prevention opportunities, it is essential to be informed of pediatric SCA etiologies. Unfortunately, etiologies frequently remain unresolved. The objectives of this study were to determine paediatric SCA etiology, and to evaluate the extent of post-SCA investigations and to assess the performance of previous cardiac evaluation in detecting conditions predisposing to SCA. In a retrospective cohort (2002–2019), all children 0–18 years with out-of-hospital cardiac arrest (OHCA) referred to Erasmus MC Sophia Children's Hospital or the Amsterdam UMC (tertiary-care university hospitals), with cardiac or unresolved etiologies were eligible for inclusion. SCA etiologies, cardiac and family history and etiologic investigations in unresolved cases were assessed. The etiology of arrest could be determined in 52% of 172 cases. Predominant etiologies in children ≥ 1 year (n = 99) were primary arrhythmogenic disorders (34%), cardiomyopathies (22%) and unresolved (32%). Events in children < 1 year (n = 73) were largely unresolved (70%) or caused by cardiomyopathy (8%), congenital heart anomaly (8%) or myocarditis (7%). Of 83 children with unresolved etiology a family history was performed in 51%, an autopsy in 51% and genetic testing in 15%. Pre-existing cardiac conditions presumably causative for SCA were diagnosed in 9%, and remained unrecognized despite prior evaluation in 13%.
Conclusion: SCA etiology remained unresolved in 83 of 172 cases (48%) and essential diagnostic investigations were often not performed. Over one-fifth of SCA patients underwent prior cardiac evaluation, which did not lead to recognition of a cardiac condition predisposing to SCA in all of them. The diagnostic post-SCA approach should be improved and the proposed standardized pediatric post-SCA diagnostics protocol may ensure a consistent and systematic evaluation process increasing the diagnostic yield.
What is Known: • Arrests in infants remain unresolved in most cases. In children > 1 year, predominant etiologies are primary arrhythmia disorders, cardiomyopathy and myocarditis. • Studies investigating sudden cardiac arrest are often limited to sudden cardiac death (SCD) in 1 to 40 year old persons, excluding infants and successfully resuscitated children. | |
What is New: • In patients with unresolved SCA events, the diagnostic work up was often incompletely performed. • Over one fifth of victims had prior cardiac evaluation before the arrest, with either a diagnosed cardiac condition (9%) or an unrecognized cardiac condition (13%). |
Graphical Abstract
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Sudden cardiac arrest (SCA) in children is estimated to account for 10% of the total mortality in the Dutch pediatric population [1]. In case of survival, the child and caregivers may face devastating consequences, varying from mild to severe, both in the short- and long-term [2].
Reported SCA incidences in children and young adult range from 0.5 to 3.9 per 100,000 person-years [1, 3,4,5,6,7,8,9]. Studies investigating SCA are often limited to sudden cardiac death (SCD) in 1 to 40 year old persons, excluding infants and successfully resuscitated children [4, 6, 9]. Still, within the pediatric population, infants have the highest out-of-hospital cardiac arrest (OHCA) incidence and lowest survival rates [3]. SCA in infants are often presumed to be multifactorial in etiology in analogy to Sudden Infant Death Syndrome/Sudden Unexplained Death in Infancy/Apparent life-threatening event (SIDS/SUDI/ALTE). However, a small percentage of these cases is likely a result of an inherited cardiac disease and their identification and early detection in relatives may have lifesaving consequences [10,11,12,13,14]. In children > 1 year, predominant etiologies are primary arrhythmia disorders, cardiomyopathy and myocarditis [4, 5, 7, 15, 16].
Postmortem genetic testing may aid in etiology identification [4, 16,17,18,19]. Identifying a (likely) pathogenic gene variant allows cascade screening within families, leading to diagnoses in pre-symptomatic carriers and potential prophylactic treatment and lifestyle modifications that may prevent new events [17, 20, 21]. Yet, after extensive postmortem investigations, 30–40% of events remain unresolved, with the highest unresolved rates found in children and young adults (1–5 and 16–20 years), warranting further investigation in these age groups [4, 6].
It is crucial to gain insight into etiologies to guide opportunities for preventing SCA. The present multicenter study investigates etiologies of pediatric SCA and assesses the diagnostic investigations performed in the SCA subgroup with unresolved etiology. In addition, we investigate the rate and diagnostic yield of cardiac evaluation performed before pediatric SCA.
Methods
Study design and setting
This retrospective observational multicenter study was conducted at two tertiary-care university hospitals in the Netherlands: the Erasmus MC Sophia Children’s Hospital (Erasmus MC) and the Amsterdam University Medical Center (AUMC). The catchment area of these hospitals covers 40% of the Dutch population. Ethical approval was waived by the local Ethics Committees of the Erasmus MC and AUMC in view of the retrospective nature of the study and all the procedures being performed were part of the routine care (MEC-2021-0618 and MEC-2017-260) and the research was conducted in accordance with the 1964 Helsinki Declaration and its later amendments.
Inclusion criteria and definitions
Definitions are specified in Supplementary Table 1 [18]. The study population consisted of children 0–18 years of age with treated OHCA referred to one of the participating university hospitals between January 2002 and August 2019. Only OHCA with a proven cardiac or unresolved etiology were included. Submersion injury in children > 8 years old was also included when these children were presumed to be able to swim. Perinatal death (within 24 h after delivery) and non-cardiac etiologies such as trauma, cerebral bleeding, sepsis and respiratory failure were excluded. In case of uncertainty about presumed non-cardiac etiology, consensus was reached by a team of specialized (pediatric) cardiologists (J.A.E.K., L.A.J.R.) and a pediatric intensivist (C.M.P.B.).
Data collection
Children were identified from two prospective population-based resuscitation databases. 1) The Erasmus MC database includes all resuscitated pediatric OHCA patients from 2002 onwards in the province of South Holland [22]. 2) The AmsteRdam REsuscitation STudies (ARREST) database, including all OHCA patients from 2005 and onwards in the province of North Holland [1]. Collected data comprised: (1) basic child characteristics, e.g. age, gender, (2) SCA characteristics, e.g. initial cardiac rhythm, etiology and return of circulation (ROC), (3) medical history, e.g. (cardiac) diagnoses, cardiac evaluation, (cardiac) surgeries before the SCA, (4) family history of cardiac disease or epilepsy, (5) post-SCA diagnostic evaluation, e.g. autopsy report, toxicology, blood culture and genetic analysis. Genetic analysis was determined for the proband, but not for family members due to the absence of informed consent for access to their medical records.
Based on this information, the etiology of SCA was determined for each child and categorized as primary arrhythmogenic disorder, cardiomyopathy, congenital heart anomaly, and other cardiac causes (cardiac neoplasms, Kawasaki disease and myocarditis) or unresolved etiology. Idiopathic ventricular fibrillation (IVF) was diagnosed with documented VF and exclusion of known cardiac, respiratory, metabolic, and toxicological etiologies through clinical evaluation [23]. Positive family history for a possible inherited cardiac condition (ICC) was defined as one or more first or second-degree relative(s) with either i. unexplained death or SCA < 40 years of age, ii. primary arrhythmia disorders, or iii. non-ischemic cardiomyopathy. Primary arrhythmia disorders included inherited syndromes or implantable cardioverter-defibrillator (ICD) or pacemaker implantation (< 40 years of age).
Statistical analysis
Categorical variables are reported as frequencies (n) and percentages (%). Continuous variables are reported as medians with first and third quartiles (Q1;Q3) or means with standard deviations (SD) depending on the normality of distribution. Baseline characteristics and outcomes are evaluated by age group (< 1 year and ≥ 1 year). Depending on applicability, differences between age groups were assessed with a Fisher exact test and an unpaired t-test or Mann–Whitney U test. Statistical significance was considered with a two-tailed p-value < 0.05. All analyses were conducted using SPSS software (IBM Corp. Released 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, New York).
Results
Basic characteristics
An inclusion overview is provided in Fig. 1. The pediatric OHCA population consisted of 1777 children, of whom 1147 died on scene or were transferred to a non-study hospital. Of the children admitted to one of the two study hospitals, 458 were excluded because of a non-cardiac etiology resulting in a final sample of 172 children. The baseline characteristics are presented in Table 1. The median age of the study population was 2.3 years (Q1;Q3 0.3–12.2), and 64% were male. The majority of children (109/172, 63%) presented with a non-shockable rhythm, especially in younger children (65/73, 89% < 1 year versus 44/99, 44% ≥ 1 year; p < 0.001). Overall, 57/172 children (33%) survived to hospital discharge.
Etiologies
The etiologies of all 172 events are presented in Table 2. Of 73 infant events, 22 were resolved (30%). Predominant etiologies were cardiomyopathies (6/73, 8%), congenital heart anomalies (6/73, 8%) and other cardiac etiologies (7/73, 10%), in particular myocarditis. Of 99 events in children ≥ 1 year old, 67 were resolved (68%). Predominant etiologies were primary arrhythmogenic disorders (34/99, 34%) and cardiomyopathies (22/99, 22%). In 48% of the total population, the etiology of the SCA event remained unresolved (51/73, 70% in the < 1 year age group versus 32/99, 32% in the ≥ 1 year age group; p < 0.001). Furthermore, among non-survivors, 65% of events (75/115) remained unresolved, while this proportion was 14% (8/57) among survivors.
Diagnostic evaluation of unresolved events
Post-SCA diagnostics appeared to be often incompletely performed in 83 unresolved events as presented in Table 3. A family history was documented in 51% (42/83). In 75 deceased children, autopsy was offered to all caregivers, but accepted in 51% (42/83). Lastly, in 15% (10/68), cardiogenetic testing was performed.
Medical and family history in relation to SCA etiology
An overview of the children that underwent cardiac evaluation prior to SCA is presented in Fig. 2. Evaluation by a pediatric cardiologist before the SCA event took place in 38/172 (22%) children. From these, 34/38 (89%) children were diagnosed with a cardiac condition, which was not always a condition predisposing to SCA. A cardiac condition predisposing to SCA was diagnosed in 16/38 (42%) children, while in 22 children (58%), the cardiac condition that presumably caused SCA had remained undiagnosed despite prior cardiac evaluation.
A more detailed summary of medical and family history is presented in Supplementary Table 2. Notably, 5/37 (14%) and 9/28 (28%) of children in the primary arrhythmogenic disorder and cardiomyopathy groups respectively had been diagnosed with the presumable SCA etiology. In addition, seven children (7/37, 19%) with SCA due to a primary arrhythmogenic disorder, suffered a prior syncope that did not result into a referral for evaluation by a pediatric cardiologist. In the unresolved etiology cases, 13% (11/83) had prior cardiac evaluation, mostly identifying unrelated congenital cardiac anomalies.
Among all SCA cases, twenty-five children (25/170, 15%) had a neurologic condition prior to SCA, half of whom had epilepsy (12/25, 48%). A positive family history of ICC was present in 13% (15/118).
Discussion
In this study of pediatric patients with out-of-hospital cardiac arrest, the etiology of arrest could be established in 52% of cases (89/172). Arrest at age < 1 year was associated with a lower proportion of the cause of arrest being identified (30%, 22/73). In patients with unresolved SCA events, the diagnostic work up was often incompletely performed. Twenty-two percent of victims (38/172) had undergone cardiac evaluation before the arrest, with either a diagnosed cardiac condition (9%, 16/172) or an unrecognized cardiac condition (13%, 22/172).
Etiologies
Comparison of etiologies to the existing literature is difficult due to the scarcity of literature on infant SCA and differences in inclusion criteria (predominantly SCD and hospital admission versus population-based). In the present study, predominant etiologies in children aged ≥ 1 year were inherited cardiac diseases, including primary arrhythmia disorders (34%, 34/99) and hypertrophic cardiomyopathy (15%, 15/99), and 32% (32/99) unresolved cases, which is comparable to previous literature [4, 5, 7, 15, 16, 24].
However, the etiology remained unresolved for infant cases in 70% (51/73), as was recognized in the only prior SCD cohort including infants which described 90% of SUDI [25]. Of the remaining resolved infant cases, 40% (9/22) had a potential inherited cardiac condition, supporting previous studies reporting causative cardiogenetic factors in up to 10% of SUDI cases [10,11,12, 26]. In the existing literature on pediatric OHCA, infants form the largest population and have the highest unresolved SCD rate underlining the importance of their inclusion in pediatric SCA studies [3, 4]. Infant arrests often occur unwitnessed during sleep at home, potentially causing a malignant ventricular arrhythmia to devolve into an asystole at the time of arrival of emergency medical services [3]. Compared to a shockable rhythm, a non-shockable presenting rhythm is associated with lower survival chances [22]. Most infants in our study presented with a non-shockable rhythm, and 86% (60/73) died. The unavailability of an electrocardiographic phenotype impairs diagnosing a potential (inherited) cardiac arrhythmia and contributes to the high proportion of unresolved etiologies. Furthermore, the finding that 7% (5/73) of the infant population suffered SCA due to myocarditis has not been previously described. This might be an underestimation because the diagnosis of myocarditis, especially postmortem, is complicated: only in 41% (21/51) an autopsy was performed and if morphologic myocardial inflammation was present, a micro-organism that may cause the disease, can often not be demonstrated.
Unlike most previous studies, we included (33%, 57/172, surviving) hospital-admitted SCA cases. This allowed for extensive diagnostic (cardiac) phenotyping, thereby increasing the chance of diagnosing the condition that caused SCA compared to the SCD population-based approach. The proportion of resolved etiologies in the surviving versus deceased patients was 55% (32/57) and 10% (12/115), respectively. The presenting rhythm was of utmost importance, with a 65% (39/60) diagnostic yield in presenting shockable rhythm versus 2% (2/109) in a non-shockable rhythm.
Alapati et al. described the only other pediatric hospital-admitted SCA cohort consisting of 44 children without medical history [29]. They described a survival rate of 50% (21% of infants and 72% ≥ 1 year) and 90% unresolved infant cases versus 16% unresolved ≥ 1-year cases [24]. The survival rate and the rate of resolved etiologies ≥ 1 year are higher than in the present study. This is an unexpected difference since Alapati et al. excluded patients with known medical conditions, such as cardiac diseases, who were included in the present study. This difference may be partly explained of the inclusion of “secondary LQTS” and ruptured arteriovenous malformation in the brain, who would have been excluded from our study [24].
Post-SCA diagnostics
Recent guidelines have focused on investigating patients with sudden unexplained death and their families [18]. One of our study's critical and awareness-raising findings is that essential diagnostics were often not performed in unresolved cases. In natural death etiologies, the choice for an autopsy is up to the child's caregivers, and a total body MRI may be offered when they do not give permission for autopsy. As many emotional and cultural considerations influence this decision and are not likely to change much over a short time frame, a significant increase in the autopsy rate is not expected. However, increasing the rate of blood culturing, toxicology screening, and obtaining a family history and cardiogenetic testing must be systematically considered. For example, the crucial step of taking a thorough familial history should be performed in every patient to streamline additional investigations into potential cardiac predispositions, in particular genetic testing.
Promising in that regard is postmortem genetic testing [16]. Bagnall et al. showed in their three-year prospective population-based study that, in unexplained SCD cases, autopsy investigation combined with genetic testing revealed a likely etiology in 27% of cases [4]. A definite clinical diagnosis was established in 13% of followed-up first-degree relatives [4]. Evaluating the yield of clinical and genetic testing in relatives was not an objective of our study. Still, others have shown diagnosis of ICC in up to 40% of families with ≥ 1 sudden and unexplained death victim [20, 27]. The importance of these findings for relatives in preventing new SCA cases needs no explanation. However, others also recently described difficulty performing structured investigations after SCA, reporting the collection of blood samples for genetic analyses in only 1% of SCA victims between 18–45 years [28]. In our centers, these findings have resulted in the development and implementation of a standardized pediatric post-SCA diagnostics protocol (Fig. 3, adapted from Stiles et al. [18], and Supplementary Table 3). A structured evaluation of children with SCA may increase the proportion of non-cardiac etiologies in OHCA. In the Erasmus MC a trend was observed towards decreasing rates of unresolved cases when the period before and after the introduction of the protocol are compared; 58% (55/95) prior and 17% (3/18) after (p = 0.001). In addition, it may increase the contribution of ICC, providing the opportunity for cascade screening and, in the case of carriership, preventive care for relatives, potentially preventing new SCA cases.
Prior evaluation or diagnosis
The finding that a substantial proportion of children suffered SCA presumably caused by a pre-SCA diagnosed cardiac condition or had undergone a prior cardiac evaluation without recognizing a condition with increased risk for SCA has not been described before in a pediatric population. This study was not designed to conclude whether these events would have been preventable nor whether all necessary investigations to exclude an underlying unrecognized cardiac etiology had been performed. However, the results suggest that not in all evaluated children a SCA risk can be recognized and if a SCA risk was recognized, not all arrests can be prevented. Treatment of children with a cardiac condition predisposing to SCA is challenging and needs a deliberate assessment of SCA risk against the potential drawbacks of mitigating lifestyle changes and treatment [29,30,31]. Moreover, the risk of SCA is multifactorial and dependent on the specific disease, variable penetration and expression, available treatment options and therapy adherence.
However, most children did not have a pre-existing diagnosed cardiac condition, which aligns with previous reports [32, 33]. Only few patients had symptoms like syncope and epilepsy was diagnosed in 7% (12/170) prior to the event. Epilepsy is difficult to interpret in relation to SCA; on one hand are children with epilepsy at increased risk of sudden death especially in case of refractory epilepsy [34, 35]. This might be the etiology of SCA in a proportion of the unresolved cases. On the other hand may primary arrhythmogenic disorders present as actual seizures that can be misdiagnosed as epilepsy, and also overlap syndromes between epilepsy and LQTS exist [35,36,37].
Recognition of SCA risk in asymptomatic children might be challenging for several reasons. First, the development of certain cardiac conditions with increased SCA risk is not predictable (e.g. myocarditis). Recognition will depend on the presence and recognition of symptoms of which SCA can be the first. Second, other cardiac conditions with more chronic appearance (e.g. cardiomyopathy and primary arrhythmia syndromes) often develop a phenotype somewhere between childhood and adolescence. Recognition therefore requires repeated cardiac evaluations during childhood. Third, specific provocative investigations are required to unmask certain cardiac conditions. These investigations (e.g. exercise testing and ECG during fever) are not routinely performed during a general cardiac work up which may lead to false reassurance [38, 39]. This might partly explain our population's 19% proportion of unrecognized primary arrhythmogenic disorders despite cardiac evaluation.
Improvement might be expected through a standardized cardiac evaluation in suspicious children, e.g. with a suspected family history or complaints of non-vasovagal syncope or atypical epilepsy, including exercise testing and potentially other provocative testing [30, 33,34,35, 40]. Increased societal awareness of suspected family history of ICC and symptoms that might indicate a potential increased risk for SCA, might help to identify the children for whom this evaluation is appropriate. Alapati et al. described 32% of SCA patients to be potentially identified as at risk for SCA by a questionnaire combined with ECG [24].
In the past decade, a significant yield in determining a population at risk for SCA has been achieved by cascade screening in families carrying a (likely) pathogenic DNA variant. However, in clinical practice, some parents still do not want their children to undergo DNA diagnostics for a familial variant due to various considerations ranging from appreciating their child’s autonomy to concerns about problems obtaining their mortgage in future. Future investigations must focus on improving the yield of recognizing children at risk for SCA by medical professionals and creating societal awareness.
Strengths and limitations
Our study aimed to describe a population of pediatric SCA patients, including infants, in relation to prior evaluation by a cardiologist and pre-existing cardiac medical history. The catchment area of this multicenter collaborative study covers almost half of the Dutch population. This, and the long inclusion period, resulted in a large patient sample size; this is a major strength in the context of the generalizability of our findings for the pediatric population. Our study also has several shortcomings. First are the retrospective study design and a significant amount of missing data. Second, there is possible overestimation of the SCA population by inclusion of unresolved etiologies without performing all necessary investigations to rule out non-cardiac etiologies. Further, inclusion started upon hospital admission. SCD at home and transport to a non-study hospital has not been considered, potentially underestimating the number of SCA. Also, as a consequence, the age distribution could have been biased because mainly infants have (unwitnessed) events in private homes, which are more often futile to resuscitative efforts, thus never reaching a hospital [3, 41].
Conclusion
SCA etiology remained largely unresolved in infants and in one-third of children aged ≥ 1 year, but essential diagnostics were often not performed. Over one-fifth of SCA patients underwent prior cardiac evaluation, but this did not lead to recognition of a cardiac condition predisposing to SCA in all of them. The diagnostic post-SCA approach should be improved and the proposed standardized pediatric post-SCA diagnostics protocol (Fig. 3) may ensure a consistent and systematic evaluation process increasing the diagnostic yield and enhancing our understanding of SCA and our ability to prevent SCA in family members with ICC. Future studies are needed to improve the recognition of children at risk for SCA.
Abbreviations
- ARREST:
-
AmsteRdam REsuscitation Studies
- ECMO:
-
Extracorporeal membrane oxygenation
- ICC:
-
Inherited cardiac condition
- ICD:
-
Implantable cardioverter-defibrillator
- OHCA:
-
Out-of-hospital cardiac arrest
- ROC:
-
Return of circulation
- SCA:
-
Sudden cardiac arrest
- SCD:
-
Sudden cardiac death
- SUDI:
-
Sudden Unexplained Death in Infancy
- VF:
-
Ventricular fibrillation
References
Bardai A, Berdowski J, van der Werf C, Blom MT, Ceelen M, van Langen IM et al (2011) Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children. A comprehensive, prospective, population-based study in the Netherlands. J Am Coll Cardiol 57(18):1822–1828
Hunfeld M, Dulfer K, Rietman A, Pangalila R, van Gils-Frijters A, Catsman-Berrevoets C et al (2021) Longitudinal two years evaluation of neuropsychological outcome in children after out of hospital cardiac arrest. Resuscitation 167:29–37
Fink EL, Prince DK, Kaltman JR, Atkins DL, Austin M, Warden C et al (2016) Unchanged pediatric out-of-hospital cardiac arrest incidence and survival rates with regional variation in North America. Resuscitation 107:121–128
Bagnall RD, Weintraub RG, Ingles J, Duflou J, Yeates L, Lam L et al (2016) A prospective study of sudden cardiac death among children and young adults. N Engl J Med 374(25):2441–2452
Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO (2009) Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 119(8):1085–1092
Winkel BG, Holst AG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL et al (2011) Nationwide study of sudden cardiac death in persons aged 1–35 years. Eur Heart J 32(8):983–990
Meyer L, Stubbs B, Fahrenbruch C, Maeda C, Harmon K, Eisenberg M et al (2012) Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review. Circulation 126(11):1363–1372
Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP et al (2020) Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 141(9):e139–e596
Lynge TH, Nielsen JL, Risgaard B, van der Werf C, Winkel BG, Tfelt-Hansen J (2023) Causes of sudden cardiac death according to age and sex in persons aged 1–49 years. Heart Rhythm 20(1):61–68
Liebrechts-Akkerman G, Liu F, van Marion R, Dinjens WNM, Kayser M (2020) Explaining sudden infant death with cardiac arrhythmias: Complete exon sequencing of nine cardiac arrhythmia genes in Dutch SIDS cases highlights new and known DNA variants. Forensic Sci Int Genet 46:102266
Tester DJ, Wong LCH, Chanana P, Jaye A, Evans JM, FitzPatrick DR et al (2018) Cardiac genetic predisposition in sudden infant death syndrome. J Am Coll Cardiol 71(11):1217–1227
Glinge C, Rossetti S, Oestergaard LB, Stampe NK, Lynge TH, Skals R et al (2023) Risk of sudden infant death syndrome among siblings of children who died of sudden infant death syndrome in Denmark. JAMA Netw Open 6(1):e2252724
Baruteau AE, Tester DJ, Kapplinger JD, Ackerman MJ, Behr ER (2017) Sudden infant death syndrome and inherited cardiac conditions. Nat Rev Cardiol 14(12):715–726
Tester DJ, Wong LCH, Chanana P, Gray B, Jaye A, Evans JM et al (2018) Exome-wide rare variant analyses in sudden infant death syndrome. J Pediatr 203(423–8):e11
Adabag AS, Luepker RV, Roger VL, Gersh BJ (2010) Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol 7(4):216–225
Semsarian C, Ingles J, Wilde AA (2015) Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. Eur Heart J 36(21):1290–1296
Wilde AAM, Semsarian C, Marquez MF, Sepehri Shamloo A, Ackerman MJ, Ashley EA et al (2022) European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases. Heart Rhythm 19(7):e1–e60
Stiles MK, Wilde AAM, Abrams DJ, Ackerman MJ, Albert CM, Behr ER et al (2021) 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm 18(1):e1–e50
Cirino AL, Ho CY (2013) Genetic testing for inherited heart disease. Circulation 128(1):e4–8
Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA (2005) Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 112(2):207–213
Campell R, Berger S, Ackerman MJ, Morrow WR, Jenkins K, Minich LL et al (2012) Pediatric sudden cardiac arrest. Pediatrics 129(4):e1094–e1102
Albrecht M, de Jonge RCJ, Nadkarni VM, de Hoog M, Hunfeld M, Kammeraad JAE et al (2021) Association between shockable rhythms and long-term outcome after pediatric out-of-hospital cardiac arrest in Rotterdam, the Netherlands: An 18-year observational study. Resuscitation 166:110–120
Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace 15(10):1389–1406
Alapati S, Strobel N, Hashmi S, Bricker JT, Gupta-Malhotra M (2013) Sudden unexplained cardiac arrest in apparently healthy children: a single-center experience. Pediatr Cardiol 34(3):639–645
Chugh SS, Reinier K, Balaji S, Uy-Evanado A, Vickers C, Mariani R et al (2009) Population-based analysis of sudden death in children: The Oregon Sudden Unexpected Death Study. Heart Rhythm 6(11):1618–1622
Sweeting J, Semsarian C (2014) Cardiac abnormalities and sudden infant death syndrome. Paediatr Respir Rev 15(4):301–306
Hofman N, Tan HL, Alders M, Kolder I, de Haij S, Mannens MM et al (2013) Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years’ experience. Circulation 128(14):1513–1521
Sharifzadehgan A, Gaye B, Bougouin W, Narayanan K, Dumas F, Karam N et al (2022) Lack of early etiologic investigations in young sudden cardiac death. Resuscitation 179:197–205
Jarman JW, Lascelles K, Wong T, Markides V, Clague JR, Till J (2012) Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 33(11):1351–1359
Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10(12):1932–1963
Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al (2015) Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36(41):2793–2867
Pilmer CM, Kirsh JA, Hildebrandt D, Krahn AD, Gow RM (2014) Sudden cardiac death in children and adolescents between 1 and 19 years of age. Heart Rhythm 11(2):239–245
Winkel BG, Risgaard B, Sadjadieh G, Bundgaard H, Haunso S, Tfelt-Hansen J (2014) Sudden cardiac death in children (1–18 years): symptoms and causes of death in a nationwide setting. Eur Heart J 35(13):868–875
Bardai A, Blom MT, van Noord C, Verhamme KM, Sturkenboom MC, Tan HL (2015) Sudden cardiac death is associated both with epilepsy and with use of antiepileptic medications. Heart 101(1):17–22
Chahal CAA, Salloum MN, Alahdab F, Gottwald JA, Tester DJ, Anwer LA et al (2020) Systematic review of the genetics of sudden unexpected death in epilepsy: potential overlap with sudden cardiac death and arrhythmia-related genes. J Am Heart Assoc 9(1):e012264
Johnson JN, Hofman N, Haglund CM, Cascino GD, Wilde AA, Ackerman MJ (2009) Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology 72(3):224–231
MacCormick JM, McAlister H, Crawford J, French JK, Crozier I, Shelling AN et al (2009) Misdiagnosis of long QT syndrome as epilepsy at first presentation. Ann Emerg Med 54(1):26–32
Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S et al (2011) Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol 57(1):51–59
Roston TM, Yuchi Z, Kannankeril PJ, Hathaway J, Vinocur JM, Etheridge SP et al (2018) The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry. Europace 20(3):541–547
Peltenburg PJ, Hoedemaekers YM, Clur SAB, Blom NA, Blank AC, Boesaard EP et al (2023) Screening, diagnosis and follow-up of Brugada syndrome in children: a Dutch expert consensus statement. Neth Heart J 31(4):133–137
Naim MY, Burke RV, McNally BF, Song L, Griffis HM, Berg RA et al (2017) Association of bystander cardiopulmonary resuscitation with overall and neurologically favorable survival after pediatric out-of-hospital cardiac arrest in the United States: a report from the cardiac arrest registry to enhance survival surveillance registry. JAMA Pediatr 171(2):133–141
Funding
H. Tan has received funding from the European Union’s Horizon 2020 research and innovation programme under acronym ESCAPE-NET, registered under grant agreement No. 733381, the COST Action PARQ (grant agreement No CA19137) supported by COST (European Cooperation in Science and Technology), and the Dutch Heart Foundation (CVON2017-15 RESCUED). All are unrelated to this study. The authors did not receive support from any organization for the submitted work and have no competing interests to declare that are relevant to the content of this article.
Author information
Authors and Affiliations
Contributions
The contributions of the authors were as follows: J.K., H.T. and C.B. had the original idea for the study. A.B. and M.A., as shared first authors, participated in its design, performed the statistical analysis, interpreted the data, drafted and critically revised the article equally. B.V. participated in data collection and interpreted the data. All co-authors revised the manuscript critically for important intellectual content. J.K., H.T. and C.B. provided supervision. All authors read and approved the final article. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Communicated by José Luis López Guillén
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bakker, A.M., Albrecht, M., Verkaik, B.J. et al. Sudden cardiac arrest in infants and children: proposal for a diagnostic workup to identify the etiology. An 18-year multicenter evaluation in the Netherlands. Eur J Pediatr 183, 335–344 (2024). https://doi.org/10.1007/s00431-023-05301-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-05301-9